secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001022079-25-000116
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q1 revenue up 12.1% to $2.65B, raises FY reported EPS guidance
--------------------------------------------------------------------------------

- Q1 net revenues $2.65B (+12.1% YoY); reported diluted EPS $1.94 (+12.8%), adjusted diluted EPS $2.21 (+8.3%).
- Organic revenue growth nearly 2.5%; requisition volume up 12.4%, organic volume down 0.9%.
- Operating income $346M (13.0% margin); adjusted operating income $406M (15.3% margin).
- Full year 2025 reported diluted EPS guidance raised to $8.62-$8.87 from prior $8.34-$8.59; adjusted EPS reaffirmed $9.55-$9.80.
- Cash from operations guidance raised to ~$1.5B from ~$1.45B; capex unchanged at ~$500M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207925000116/0001022079-25-000116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207925000116/dgx-20250422.htm
  HTML page:      https://secwatch.observer/filing/0001022079-25-000116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer